All articles tagged with #tonmya
Tonix Pharmaceuticals' drug Tonmya has received FDA approval for treating fibromyalgia in adults, marking the first new therapy in over 15 years for this condition. The medication, a non-opioid, once-daily sublingual tablet, demonstrated significant pain reduction in clinical trials and is expected to be available in the US by late 2025.
The FDA has approved Tonmya, a new treatment for fibromyalgia developed by Tonix Pharmaceuticals, marking the first new FDA-approved fibromyalgia drug in over 15 years. The drug is a once-daily sublingual tablet shown to significantly reduce pain in clinical trials. Following the announcement, Tonix's stock initially surged but then declined, reflecting market volatility and investor reactions.
Tonix Pharma has received FDA approval for its drug Tonmya, which is used to treat certain mental health conditions, marking a significant milestone for the company.
Tonix Pharmaceuticals received FDA approval for Tonmya™, a non-opioid, sublingual tablet for fibromyalgia in adults, marking the first new treatment in over 15 years. The drug demonstrated significant pain reduction in Phase 3 trials and is expected to launch in Q4 2025, targeting over 10 million affected U.S. adults.